DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- Revenue, 2025
- $11.0B
- YoY, 2025
- +11.8%
- 5-year CAGR
- +3.2%
- 10-year CAGR
- +3.9%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $11.0B | +11.8% |
| 2024 | $9.9B | +6.7% |
| 2023 | $9.3B | −6.4% |
| 2022 | $9.9B | −8.4% |
| 2021 | $10.8B | +14.3% |
| 2020 | $9.4B | +22.1% |
| 2019 | $7.7B | +2.6% |
| 2018 | $7.5B | +1.7% |
| 2017 | $7.4B | +2.6% |
| 2016 | $7.2B | −3.7% |
| 2015 | $7.5B | +0.8% |
| 2014 | $7.4B | +4.0% |
| 2013 | $7.1B | −3.2% |
| 2012 | $7.4B | −0.1% |
| 2011 | $7.4B | +1.8% |
| 2010 | $7.3B | −2.6% |
| 2009 | $7.5B | +2.8% |
| 2008 | $7.2B | +8.1% |
| 2007 | $6.7B | — |